155 related articles for article (PubMed ID: 38521876)
21. Triazole based novel molecules as potential therapeutic agents: Synthesis, characterization, biological evaluation, in-silico ADME profiling and molecular docking studies.
Şahin İ; Çeşme M; Özgeriş FB; Tümer F
Chem Biol Interact; 2023 Jan; 370():110312. PubMed ID: 36535312
[TBL] [Abstract][Full Text] [Related]
22. Antibacterial and antifungal metal based triazole Schiff bases.
Chohan ZH; Hanif M
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):944-53. PubMed ID: 22803673
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and Evaluation of Some Dibromoquinazoline-sulphonamide Hybrids and some Schiff´s Base Analogs for their Cytotoxic Activity.
Ahmed MF; El-Haggar R
Anticancer Agents Med Chem; 2017 Nov; 17(11):1563-1569. PubMed ID: 28356022
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and molecular docking study of some 2-((7-chloroquinolin-4-yl) amino) benzohydrazide Schiff bases as potential Eg5 inhibitory agents.
Kavalapure RS; Alegaon SG; Venkatasubramanian U; Priya AS; Ranade SD; Khanal P; Mishra S; Patil D; Salve PS; Jalalpure SS
Bioorg Chem; 2021 Nov; 116():105381. PubMed ID: 34601297
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, characterization, in vitro antimycobacterial and cytotoxicity evaluation, DFT calculations, molecular docking and ADME studies of new isomeric benzimidazole-1,2,3-triazole-quinoline hybrid mixtures.
Nyoni NTP; Ncube NB; Kubheka MX; Mkhwanazi NP; Senzani S; Singh T; Tukulula M
Bioorg Chem; 2023 Dec; 141():106904. PubMed ID: 37832224
[TBL] [Abstract][Full Text] [Related]
26. Bioactive platinum complex of ligand bearing pyrimidine skeleton: DNA/BSA binding, molecular docking, anticancer, antioxidant and antimicrobial activities.
Sankarganesh M; Adwin Jose PR; Dhaveethu Raja J; Vijay Solomon R; Dorothy Sheela C; Gurusamy S
J Biomol Struct Dyn; 2022 Sep; 40(15):6683-6696. PubMed ID: 33634734
[TBL] [Abstract][Full Text] [Related]
27. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
[TBL] [Abstract][Full Text] [Related]
28. Rational Identification of Hsp90 Inhibitors as Anticancer Lead Molecules by Structure Based Drug Designing Approach.
Gupta SD; Swapanthi PS; Bhagya D; Federicci F; Mazaira GI; Galigniana MD; Subrahmanyam CVS; Gowrishankar NL; Raghavendra NM
Anticancer Agents Med Chem; 2020; 20(3):369-385. PubMed ID: 31713499
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, crystal structures, antiproliferative activities and reverse docking studies of eight novel Schiff bases derived from benzil.
Tan XJ; Wang D; Hei XM; Yang FC; Zhu YL; Xing DX; Ma JP
Acta Crystallogr C Struct Chem; 2020 Jan; 76(Pt 1):44-63. PubMed ID: 31919307
[TBL] [Abstract][Full Text] [Related]
30. Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer.
Nafie MS; Boraei ATA
Bioorg Chem; 2022 May; 122():105708. PubMed ID: 35290929
[TBL] [Abstract][Full Text] [Related]
31. Halting Tumor Progression via Novel Non-Hydroxamate Triazole-Based Mannich Bases MMP-2/9 Inhibitors; Design, Microwave-Assisted Synthesis, and Biological Evaluation.
Albelwi FF; Teleb M; Abu-Serie MM; Moaty MNAA; Alsubaie MS; Zakaria MA; El Kilany Y; Aouad MR; Hagar M; Rezki N
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638665
[TBL] [Abstract][Full Text] [Related]
32. [Synthesis and antitumor activity of anthracene-9-carbaldehyde amino-s-triazole Schiff-bases with side-chain of S-acetic acid].
Hu GQ; Dong XL; Xie SQ; Huang WL
Yao Xue Xue Bao; 2008 Jan; 43(1):50-3. PubMed ID: 18357731
[TBL] [Abstract][Full Text] [Related]
33. DFT calculations, molecular docking,
G S; K D; P S; N B
J Biomol Struct Dyn; 2023; 41(22):12997-13014. PubMed ID: 36752337
[TBL] [Abstract][Full Text] [Related]
34. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
Zhang YZ; Liu HL; He QS; Xu Z
Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
[TBL] [Abstract][Full Text] [Related]
35. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, biological activities and DFT calculation of novel 1,2,4-triazole Schiff base derivatives.
Jin RY; Zeng CY; Liang XH; Sun XH; Liu YF; Wang YY; Zhou S
Bioorg Chem; 2018 Oct; 80():253-260. PubMed ID: 29966871
[TBL] [Abstract][Full Text] [Related]
37. A review: Pharmacological aspects of metal based 1,2,4-triazole derived Schiff bases.
Zafar W; Sumrra SH; Chohan ZH
Eur J Med Chem; 2021 Oct; 222():113602. PubMed ID: 34139626
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors.
El-Sherief HAM; Youssif BGM; Abbas Bukhari SN; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Eur J Med Chem; 2018 Aug; 156():774-789. PubMed ID: 30055463
[TBL] [Abstract][Full Text] [Related]
39. Discovery of new 1,4-disubstituted 1,2,3-triazoles:
Şahin İ; Çeşme M; Yüce N; Tümer F
J Biomol Struct Dyn; 2023 Mar; 41(5):1988-2001. PubMed ID: 35057704
[TBL] [Abstract][Full Text] [Related]
40. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA
Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
